SNCA and Lewy body dementia: These observations suggest that α-synuclein phosphorylation is not only physiologically crucial in the pathogenesis of Lewy body diseases but is also a potential biomarker for the diagnosis and monitoring of the progression of Parkinson’s disease and related disorders.